Bingying Y. Du - Publications

Metabolic factor-based machine learning model for mortality prediction in acute hepatitis E: Development and validation from a dual-center cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 04, 2025

Mr BMT Achieves Systemic Macrophage Replacement With Preservation of Tissue Homeostasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 05, 2025

The evolution of microglia replacement: A new paradigm for CNS disease therapy.

Journal: Cell stem cell

Published: September 30, 2025

Machine learning models based on adipocyte fatty acid-binding protein help predict the chronic and lethal outcomes of patients with drug-induced liver injury.

Journal: Postgraduate medical journal

Published: May 08, 2025

Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD.

Journal: Cell reports. Medicine

Published: April 14, 2025

Decoding sexually dimorphic proteomic landscapes in the context of aging and mortality.

Journal: Communications medicine

Published: March 06, 2025

Lipoprotein-Based Nanocatalyst Enables Targeted Treatment of APAP-Induced Liver Injury via Enhanced Macropinocytosis.

Journal: Advanced healthcare materials

Published: January 29, 2025

Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy.

Journal: CNS neuroscience & therapeutics

Published: October 18, 2024

Estimation of Machine Learning-Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study.

Journal: JMIR aging

Published: July 10, 2024

Causal effects of female reproductive features on nonalcoholic fatty liver disease: A mendelian randomization study.

Journal: The journal of gene medicine

Published: February 21, 2024

The associations between peripheral inflammatory and lipid parameters, white matter hyperintensity, and cognitive function in patients with non-disabling ischemic cerebrovascular events.

Journal: BMC neurology

Published: December 30, 2023

Hyperforin ameliorates neuroinflammation and white matter lesions by regulating microglial VEGFR2 /SRC pathway in vascular cognitive impairment mice.

Journal: CNS neuroscience & therapeutics

Published: November 26, 2023